相关实验视频
Updated: Sep 10, 2025

11:51
Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
12.0K
新型quinazoline衍生物作为多功能生物活性剂的合成,生物评估和分子对接
Djihane Zine1, Mohamed Abdesselem Dems2, Mehdi Boutebdja3
1Laboratory of Synthesis of Molecules with Biological Interest, Faculty of Exact Sciences, Mentouri - Constantine 1 University, 25000 Constantine, Algeria.
Bioorganic chemistry
|August 24, 2025
概括
研究人员使用单多组分反应合成了新型quinazoline衍生物. 一些化合物表现出显著的抗氧化剂,乙胆酶 (AChE) 和丁胆酶 (BChE) 抑制活性,以及抗菌性质.
科学领域:
- 医学化学
- 有机合成
- 药理学
背景情况:
- 已知基纳衍生物具有多种生物活性.
- 开发具有多功能性质的新型异环化合物对于药物发现至关重要.
研究的目的:
- 合成一系列新的1,2-二基纳和基纳衍生物.
- 评估合成化合物的抗氧化剂,抗胆酶和抗菌活性.
主要方法:
- 使用DABCO催化剂的2-aminobenzophenone,化物和酸进行单多元反应.
- 通过NMR,HRMS和X射线结晶学来阐明结构.
- 在体外抗氧化剂测试 (DPPH,ABTS,铁,降低功率),埃尔曼胆酶抑制方法,抗菌查和分子对接.
主要成果:
- 成功合成了新型金纳衍生物.
- 化合物4d和4c表现出与BHT和BHA相比较强大的抗氧化活性.
- 衍生物5d和4f显示出强烈的乙胆酶 (AChE) 抑制,而4b则抑制了丁胆酶 (BChE).
- 化合物4b,4d和4f具有中等到良好的抗菌活性.
- 分子对接支持实验结果,并阐明了结构活动关系.
结论:
- 合成的奎纳衍生物具有显著的多功能生物活性.
- 这些化合物代表了开发新治疗剂的有希望的支架.
- 对这些衍生物的进一步研究可能会导致新药候选物.
相关概念视频
Structure-Activity Relationships and Drug Design
1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
647
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
647

